|
|
| Lightlake Therapeutics Inc. |
|
| Company Information |
Lightlake Therapeutics Inc.
CEO: Roger Crystal
Issue Type: Common Stock
Sector: Medical
Industry: Medical |
|
| Management Team |
Dr.
Michael Sinclair
Chairman
Dr. Roger Crystal
Chief Executive Officer
Kevin Pollack, Esq.
Chief Financial Officer
Dr. David Sinclair
Chief Science Officer
(Emeritus)
|
|
|
| We are a London-based biopharmaceutical company
using our expertise in opioid antagonists to build a platform of
innovative solutions to common addictions and related disorders. We
hold patents covering the use of intranasal naloxone to treat Binge
Eating Disorder (“BED”) as well as patents covering addiction to
drugs including cocaine, amphetamine, and MDMA. We are currently
focused on advancing our treatment for BED, which has successfully
completed Phase II clinical trials, and a Phase II trial is planned
for the indication of Bulimia Nervosa. We are also applying our
technology to develop a treatment for managing the complications of
opioid drug addiction in collaboration with the National Institute
on Drug Abuse (NIDA), part of the National Institutes of Health. |
| Recent News |
 |
LLTP
to Develop Opioid Drug Treatment with National Institute on
Drug Abuse
April 24, 2013 |
|
|
LLTP
Provides Guidance on Company Operations
April 4, 2013 |
|
|
LLTP Presents Clinical Trial Results to APA
March 27, 2013 |
|
|
LLTP Appoints Kevin Pollack New CFO
November 29, 2012 |
|
|
LLTP Appoints
Dr. David Kessler as Strategic Advisor
September 24, 2012 |
|
|
LLTP Announces Positive Preliminary Phase II Clinical Trial
Results of Binge Eating Disorder Treatment May3,
2012 |
|
|
LLTP
Appoints Pollack to Board April 17, 2012 |
|
|
LLTP Responds to Questions
About Trading Activity Feb 1, 2012 |
|
|
LLTP Applies Patented Technology to New
Treatment for PMS Overeating |
|
|
LLTP Discusses New Opiate Overdose
Treatment with King's College, London Jan 3, 2012 |
|
|
LLTP to Conduct Phase II Testing of New Bulimia Nervosa
Oct 05, 2011 |
|
|
|
|
Porter, LeVay & Rose,
Inc.
Michael J. Porter
mike@plrinvest.com
212-564-4700
|
Pacific Stock Transfer, Inc.
4045 South Spencer Street, Suite 403
Las Vegas, NV 89119 |
Peter Messineo, CPA
1982 Otter Way
Palm Harbor, FL 34685
727-421-6268
|
| |
|
|
|
